KLK3 and posterior cortical atrophy: The NHANES cross-sectional design offers population representativeness but cannot establish temporal causality, while the case-control study strengthens outcome specificity (biopsy-confirmed cases, PSA-negative controls) despite residual confounding risks; consistent dose-response trends across designs reinforce the robustness of the DEHP-PCa association.